SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-022497
Filing Date
2024-04-26
Accepted
2024-04-26 16:31:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20018274x2_defa14a.htm DEFA14A 11589
2 ny20018274x2_na01.jpg GRAPHIC 1262549
3 ny20018274x2_na02.jpg GRAPHIC 940439
  Complete submission text file 0001140361-24-022497.txt   3044071
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38599 | Film No.: 24884396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)